Get started
Northwest Biotherapeutics, Inc.Northwest Biotherapeutics, Inc.Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

NWBO chart


Full chart

NWBO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪380.59 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0645 USD
Net income (FY)
‪−62.60 M‬ USD
Revenue (FY)
‪1.93 M‬ USD
Shares float
‪1.14 B‬
Beta (1Y)
2.04

Employees


Employees (FY)
22
Change (1Y)
0
Revenue / Employee (1Y)
‪87.82 K‬ USD
Net income / Employee (1Y)
‪−2.85 M‬ USD

About Northwest Biotherapeutics, Inc.


Sector
Health Technology
CEO
Linda F. Powers
Headquarters
Bethesda
Website
nwbio.com
Founded
1996
FIGI
BBG000BKSMM9
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NWBO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NWBO is 0.3049 USD — it has increased by 16.82% in the past 24 hours. Watch Northwest Biotherapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Northwest Biotherapeutics, Inc. stocks are traded under the ticker NWBO.
NWBO stock has risen by 12.47% compared to the previous week, the month change is a −3.70% fall, over the last year Northwest Biotherapeutics, Inc. has showed a −66.49% decrease.
NWBO reached its all-time high on Jan 8, 2002 with the price of 1,420.8000 USD, and its all-time low was 0.1400 USD and was reached on Apr 25, 2017. View more price dynamics on NWBO chart.
See other stocks reaching their highest and lowest prices.
NWBO stock is 24.81% volatile and has beta coefficient of 2.04. Track Northwest Biotherapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Northwest Biotherapeutics, Inc. there?
Today Northwest Biotherapeutics, Inc. has the market capitalization of ‪380.59 M‬, it has increased by 0.73% over the last week.
Yes, you can track Northwest Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Northwest Biotherapeutics, Inc. is going to release the next earnings report on Nov 21, 2024. Keep track of upcoming events with our Earnings Calendar.
NWBO net income for the last quarter is ‪−17.87 M‬ USD, while the quarter before that showed ‪−18.31 M‬ USD of net income which accounts for 2.42% change. Track more Northwest Biotherapeutics, Inc. financial stats to get the full picture.
No, NWBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 22.00 employees. See our rating of the largest employees — is Northwest Biotherapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Northwest Biotherapeutics, Inc. EBITDA is ‪−60.24 M‬ USD, and current EBITDA margin is ‪−2.78 K‬%. See more stats in Northwest Biotherapeutics, Inc. financial statements.
Like other stocks, NWBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Northwest Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Northwest Biotherapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Northwest Biotherapeutics, Inc. stock shows the sell signal. See more of Northwest Biotherapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.